Cancer patients and
What is radiation oncology? Here, patients and their families can find a comprehensive guide of radiotherapy treatments in Belgium.
As a medical professional, you're familiar with the basics of radiotherapy. Visit the following pages for a more elaborate approach on the topic.
Radiation oncology is not like other medical specialties. This section deals with existing quality initiatives and cost-effectiveness.
Belgian Radiation Oncology Awareness and Visibility Organization
“Fighting Breast Cancer with Innovative Radiotherapy… for everyone?”
Venue: SQUARE – Brussels Meeting Centre Date: 17/11/2018 Cost: free - register
Topic: “Fighting Breast Cancer with Innovative Radiotherapy… for everyone?”
8h45 – 09h15: Venue opens and welcome coffee
09h15 – 09h20: Welcome Address (Steven Cuypers, Co-President BRAVO)
09h20 – 09h35: Breast cancer radiotherapy: exposure of the heart and lungs (Dr F. K. Duane, MRC Clinical Research Fellow Clinical Oncology – Oxford University Hospitals)
09h40 – 09h55: Oncoplasty and Radiotherapy: enemy brothers or… the best friends? (Dr P. Cusumano, Surgical Oncology (Breast and pelvis) - CHU Liège)
10h00 – 10h15: Harnessing radiotherapy to boost immune responses against breast cancer (Prof. M. Piccart, Professor of Medical Oncology - Université Libre de Bruxelles (ULB) and Scientific Director - The Jules Bordet Institute Brussels)
10h20 – 10h35: Can innovative techniques save lives? (Prof. L. Veldeman, Radiation Oncologist - UZ Gent)
10h40 – 11h10: Break
11h10 – 11h25: Oncoplasty and Radiotherapy in Autologous Breast Reconstruction (Dr F. Stillaert, Plastic Surgeon - UZ Gent)
11h30 – 11h45: Patient testimonial
11h45 – 12h10: Closing the Gap. 50% less mortality in 10 years as a bold goal (Jurgen Vanpraet, Director Think Pink Belgium)
12h10 – 12h20: Q&A
12h25 – 12h30: Closing remarks (Prof. Dr G. De Meerleer, Co-President BRAVO)
12h30 – 13h30: Lunch
Moderators: Dr J.-F. Daisne, Prof. Dr W. De Neve, Dr C. Kirkove, Dr V. Remouchamps, Prof. Dr E. Van Limbergen
Note: Accreditation is applied for in category 6 – Ethics and Economy
On the occasion of this symposium, BRAVO developed an expert document about the therapeutic value of modern radiotherapy.
(Steven Cuypers, Co-President BRAVO for the industry)
(Prof Dr. Yolande Lievens, Chair Radiation Oncology Department at University Hospital Ghent)
(Prof. Dr Dirk Verellen – Iridium Kankernetwerk, Antwerp; VUB, Faculteit Geneeskunde en Farmacie)
(Prof. Dr Dirk Van Gestel – Chair Radiation Oncology Department at Institut Jules Bordet, Université Libre de Bruxelles, Brussels)
(Prof. David Jaffray – Senior Scientist at Princess Margaret Cancer Centre; Executive VP Technology and Innovation at UHN; co-author of “Expanding global access to radiotherapy” in The Lancet (2015))
(Prof. Dr Gert De Meerleer – Co-President BRAVO for the physicians; Radiation Oncologist at University Hospital Leuven)